Agios Pharmaceuticals, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Cambridge, MA
AGIO chart
What traders are saying about $AGIO
Latest postsAgios Pharmaceuticals, Inc. news
- Form 144 AGIOS PHARMACEUTICALS For: 27 October By Investing.com
Investing.com Nigeria ·
- Agios Pharmaceuticals, Inc. Estimates – NASDAQ:AGIO
TradingView ·
- Form 144 AGIOS PHARMACEUTICALS For: 21 October By Investing.com
Investing.com South Africa ·
- Form 144 AGIOS PHARMACEUTICALS For: 22 October By Investing.com
Investing.com Nigeria ·
- A 500-share sale is proposed by Agios (NASDAQ: AGIO) officer Sarah Gheuens.
Stock Titan ·
- Agios Pharmaceuticals (AGIO) Edges Higher: AGIO Tests $37.18 as Bulls Push Toward Resistance - PCR Mean Reversion
https://www.dars.gov.et/ ·
- Agios Pharmaceuticals Officer Sarah Gheuens Files Form 144 to Sell 1,489 Shares via Stock Option Exercise
Kalkine Media ·
- DHR Q3 Earnings Beat on Biotechnology Strength, Sales in Line
Yahoo Finance ·
- Did Priority Review Just Shift Agios Pharmaceuticals' (AGIO) Investment Narrative?
Yahoo Finance ·
- A Phase 3 Win and a 130% Takeover Premium Lit Up Rare Blood-Disease Stocks on Monday
Yahoo Finance ·
- FDA Decision Watch: What Investors Need To Know About Four Upcoming Drug Rulings
stocktwits.com ·
- Danaher Gears Up to Post Q3 Earnings: What Lies Ahead for the Stock?
Yahoo Finance ·
Agios Pharmaceuticals, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $54.0M | $36.5M | $26.8M | $14.2M |
| Net income | -$413.0M | $674.0M | -$352.0M | -$232.0M |
| Diluted EPS | $-7.12 | $11.64 | $-6.33 | $-4.23 |
| Total assets (year end) | $1.30B | $1.66B | $937.1M | $1.24B |
| Cash and equivalents (year end) | $89.1M | $76.2M | $88.2M | $139.3M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Agios Pharmaceuticals, Inc.
- Ticker
- AGIO (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Cambridge, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1439222
- Former names
- AGIOS PHARMACEUTICALS INC
Frequently asked questions
What exchange is Agios Pharmaceuticals, Inc. listed on?
Agios Pharmaceuticals, Inc. trades on the Nasdaq under the ticker symbol AGIO.
What industry is Agios Pharmaceuticals, Inc. in?
Agios Pharmaceuticals, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Agios Pharmaceuticals, Inc. headquartered?
Agios Pharmaceuticals, Inc.'s business address on file with the SEC is in Cambridge, MA.
When does Agios Pharmaceuticals, Inc.'s fiscal year end?
Agios Pharmaceuticals, Inc.'s fiscal year ends on December 31.
How much revenue did Agios Pharmaceuticals, Inc. report?
Agios Pharmaceuticals, Inc. reported $54.0M in revenue for calendar year 2025, according to its SEC filings.